Edition:
United States

Cipla Ltd (CIPL.BO)

CIPL.BO on Bombay Stock Exchange

602.05INR
19 Jan 2018
Change (% chg)

Rs-1.15 (-0.19%)
Prev Close
Rs603.20
Open
Rs604.95
Day's High
Rs605.00
Day's Low
Rs600.00
Volume
47,128
Avg. Vol
109,169
52-wk High
Rs663.00
52-wk Low
Rs479.00

Latest Key Developments (Source: Significant Developments)

Kiadis Pharma Proposes Subhanu Saxena, Former Cipla CEO, As New Supervisory Board Member
Tuesday, 16 Jan 2018 01:00am EST 

Jan 16 (Reuters) - KIADIS PHARMA NV ::KIADIS PHARMA PROPOSES FORMER CIPLA CEO SUBHANU SAXENA AS NEW SUPERVISORY BOARD MEMBER.SUPERVISORY BOARD WILL NOMINATE SUBHANU SAXENA TO BE APPOINTED AS NEW MEMBER OF SUPERVISORY BOARD​.  Full Article

Cipla Launches Q-Tib Globally
Thursday, 30 Nov 2017 02:29am EST 

Nov 30 (Reuters) - Cipla Ltd ::SAYS CIPLA LAUNCHES Q-TIB GLOBALLY.SAYS GOT APPROVAL FOR PRODUCT Q-TIB FROM WORLD HEALTH ORGANISATION.Q-TIB WILL HELP PREVENT TUBERCULOSIS INFECTION IN PEOPLE LIVING WITH HIV.  Full Article

Cipla gets final approval for generic Dacogen​
Sunday, 19 Nov 2017 10:22pm EST 

Nov 20 (Reuters) - Cipla Ltd :Says ‍Cipla receives final approval for generic Dacogen​.Drug indicated for treatment of patients with myelodysplastic syndromes.Product is available for shipping immediately.  Full Article

Cipla gets final approval for generic Pulmicort Respules
Thursday, 16 Nov 2017 10:25pm EST 

Nov 17 (Reuters) - Cipla Ltd ::Cipla receives final approval for generic Pulmicort Respules.Drug indicated for maintenance treatment of asthma, as prophylactic therapy in children 12 months to 8 years of age.Product available for shipping immediately.  Full Article

India's Cipla Sept qtr consol profit up about 19 pct
Tuesday, 7 Nov 2017 03:26am EST 

Nov 7 (Reuters) - Cipla Ltd :Sept quarter consol net profit 4.23 billion rupees versus profit of 3.54 billion rupees last year.Consensus forecast for sept quarter consol net profit was 4.20 billion rupees.Sept quarter consol net sales 39.88 billion rupees versus 36.72 billion rupees last year.  Full Article

Cipla says US unit gets USFDA final approval for generic Renvela tablets‍​
Friday, 27 Oct 2017 01:23am EDT 

Oct 27 (Reuters) - Cipla Ltd :Says us subsidiary receives final approval for generic Renvela tablets‍​.  Full Article

Cipla's U.S. unit gets final FDA nod for generic Renvela tablets
Thursday, 26 Oct 2017 11:26pm EDT 

Oct 27 (Reuters) - Cipla Ltd ::Says co's U.S. unit gets final FDA nod for generic Renvela tablets ‍​.  Full Article

Cipla says co on target to ramp-up launch trajectory in U.S.‍​
Friday, 11 Aug 2017 04:19am EDT 

Aug 11 (Reuters) - Cipla Ltd :Says "we are on target to ramp-up our launch trajectory in the U.S.”‍​.  Full Article

India's Cipla June-qtr consol profit up about 21 pct
Friday, 11 Aug 2017 04:09am EDT 

Aug 11 (Reuters) - Cipla Ltd :June quarter consol net profit 4.09 billion rupees versus 3.39 billion rupees last year.Consensus forecast for june quarter consol net profit was 3 billion rupees.June quarter consol net sales 34.32 billion rupees versus 35.56 billion rupees last year.  Full Article

India's Cipla launches rectal artesunate suppositories for severe malaria in young children
Tuesday, 25 Jul 2017 06:04am EDT 

July 25 (Reuters) - Cipla Ltd :Launches quality-assured rectal artesunate suppositories for severe malaria in young children.Says co's RAS product will now soon be available in four sub-Saharan countries.  Full Article

BRIEF-Kiadis Pharma Proposes Subhanu Saxena, Former Cipla CEO, As New Supervisory Board Member

* KIADIS PHARMA PROPOSES FORMER CIPLA CEO SUBHANU SAXENA AS NEW SUPERVISORY BOARD MEMBER